Quantum-Si Incorporated - Company Research Report
Company Overview
- Name: Quantum-Si Incorporated
- Mission: Quantum-Si aims to power the proteomic era by making protein sequencing accessible to every lab, everywhere, through innovative single-molecule proteomics technologies.
- Founded: 2013
- Founder: Jonathan Rothberg
- Key People:
- Jeff Hawkins, Chief Executive Officer - Visionary leader focused on democratizing proteomic analysis.
- Headquarters: Branford, Connecticut, USA
- Number of Employees: No information is available
- Revenue: Quantum-Si posted $400K in Q4 revenues for 2024.
- Notable For: Known as "The Protein Sequencing Company," Quantum-Si is recognized for developing the first Next-Generation Protein Sequencer™, Platinum®, which brings single-molecule proteomics to research settings globally.
Products
Platinum® Next-Generation Protein Sequencer™
- High-Level Description: The Platinum® is an end-to-end benchtop solution that enables deep proteomic insights by detecting single amino acids through kinetic signatures, offering unprecedented sensitivity to protein variants.
- Key Features:
- Scalable: Requires less than 3 hours of hands-on time and fits seamlessly into existing workflows.
- Accessible: Cost-effective, requires no dedicated lab space, and is operable by users without advanced expertise.
- Insight-Generating: Provides single-molecule amino acid resolution and direct protein detection, facilitating proteoform and modification interrogation.
V3 Sequencing Kit
- High-Level Description: A recent upgrade aimed at enhancing protein insights with added functionalities.
- Key Features:
- Enhanced Protein Insights: Resolves errors by enabling Aspartic acid (D) recognition.
- Simplified Workflow: Features AI-powered analysis tools that streamline results with less manual intervention.
- Progressive Innovation: Contains cutting-edge sequencing tools that allow research to advance at a greater pace.
Library Preparation and Sequencing Kits
- High-Level Description: These kits include reagents necessary for protein digestion and peptide functionalization, aligning with the semiconductor chips for sequencing.
- Key Features: Sequencing chips, recognizers, and aminopeptidases for comprehensive sequencing workflows.
Recent Developments
New Products Launched
- V3 Sequencing Kit: Enhances single-amino acid resolution, specifically Aspartic acid recognition, and optimizes workflow tempo through AI-driven technology.
New Features and Upgrades
- Platinum Analysis Software: Updates in April 2024 resulted in higher data output, increased precision, and shorter processing times, enhancing the efficiency of protein sequencing analysis.
Partnerships and Collaborations
- Northwestern Proteomics Center of Excellence: Partnered for a webinar discussing advancements in proteoform analysis using top-down mass spectrometry and single-molecule sequencing.
- Liberate Bio: Integrated Quantum-Si’s sequencing platform to elevate gene therapy development.
Business and Industry Events
- Investor & Analyst Event: Scheduled in New York City on November 20th, 2024.
Other Notable News
- Leadership Appointments: Chuck Kummeth, former President and CEO of Bio-Techne, joined as independent Chairman of the Board of Directors in May 2024. Paula Dowdy, a former Illumina and Cisco Systems executive, was appointed to the Board of Directors in March 2024.
- Global Expansion: Introduced the Next-Generation Protein Sequencer™ in Japan through a new distribution partnership in January 2024.
This report encapsulates the core activities and recent advancements of Quantum-Si without additional commentary beyond the data available.
